Biologic contrasts between medullipin I and vasoactive glyceryl compounds.

@article{Muirhead1989BiologicCB,
  title={Biologic contrasts between medullipin I and vasoactive glyceryl compounds.},
  author={E. Muirhead and L. W. Byers and B. Brooks and P. Brown and J. Pitcock},
  journal={The American journal of the medical sciences},
  year={1989},
  volume={298 2},
  pages={
          93-103
        }
}
Medullipin I causes a delayed onset depressor response when injected intravenously into rats. The glyceryl compounds selachyl alcohol (SA) and monoolein (MO) cause similar vasodepression. The neutral lipid 1-O-hexadecyl-2-acetyl-sn-glycerol (HAG) was suggested by Blank et al to be medullipin I (Med I, formerly ANRL). Biologic comparisons were made between Med I and various glyceryl compounds, including SA, MO, HAG, alkyl glyceryl ethers of phosphatidyl choline (termed APRL by us), diacylated SA… Expand
Biologic differences between vasodilator prostaglandins and medullipin I.
Medullopressin: A New Pressor Activity from the Renal Medulla
Discovery of the Renomedullary System of Blood Pressure Control and Its Hormones
The vasodepressor function of the kidney: prostaglandin E2 is not the principal vasodepressor lipid of the renal medulla
SECRETION OF MEDULLIPIN I BY ISOLATED KIDNEYS PERFUSED UNDER ELEVATED PRESSURE

References

SHOWING 1-10 OF 29 REFERENCES
Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells.
Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.
The Reno‐Hepatic Axis of Blood Pressure Control: Further Studies
...
1
2
3
...